AGL
AGL
US00857U2069
agilon health, inc.
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
1.38B EUR
1.8B EUR
131.35M EUR
285.75M EUR
Enterprise Value
1.27B EUR
1.73B EUR
24.77M EUR
148.85M EUR
Valuation Multiples
Trailing P/E
--
--
--
--
Forward P/E
34.31x
--
--
--
Price to Sales
0.23x
0.3x
0.02x
0.06x
Price to Book
6.08x
7.91x
0.72x
2.25x
EV/Revenue
0.22x
0.29x
0x
0.03x
EV/EBITDA
-5.3x
--
--
--
Price to FCF (P/FCF)
--
--
--
--
EV/FCF
--
--
--
--
FCF Yield
-10.53%
-5.89%
-65.01%
-37.1%
ende